Participated · Series A · Mar 2023

Mindset Health builds app-based digital hypnotherapy programs that combine world-class health specialists and clinical research with a proprietary scalable technology platform to deliver evidence-based audio therapies. Its platform currently powers three apps addressing medically-diagnosed irritable bowel syndrome, menopause, and smoking cessation. The company reports top user markets as the US (38%), Australia (19%), and the UK (15%). With US$12 million raised in an oversubscribed Series A, Mindset plans to broaden channels-to-market and scale distribution to meet increasing global demand. It intends to launch new apps for conditions including anxiety and depression, sleep, and chronic pain, and to enhance personalization and features in existing programs. Mindset will continue clinical and real-world research with partners such as Baylor University and Monash University to strengthen evidence of health and economic outcomes. The company is also recruiting across software engineering and healthcare sales to support growth. Mindset Health builds evidence-based, hypnosis-based therapeutic mobile apps for self-management of physical and mental health conditions. Its flagship app, Nerva, delivers a gut-directed hypnotherapy program for IBS and helps more than 10,000 people a month. The company reports that 89% of people who finished the initial program said they had an improved ability to manage their symptoms. Mindset partners with health researchers and clinicians and plans to expand its platform to deliver new programs targeting menopause, depression, and chronic pain. The Y Combinator-backed startup will use its recent seed raise to scale to 100,000 users a month, grow its team from 12 to 40, and run several randomized controlled trials. Founders Chris and Alex Naoumidis aim to automate hypnosis-based approaches to offer scalable, consistent, lower-cost alternatives to in-person therapy. Mindset Health builds hypnotherapy-driven apps positioned as self-management tools rather than therapy, with a general Mindset toolkit and condition-specific products such as Nerva for irritable bowel syndrome. The company was founded by brothers Chris and Alex Naoumidis, who turned to hypnotherapy after earlier startup work and developed the apps based on those experiences. Mindset’s products were designed with clinicians — the initial app with Dr. Michael Japko and the IBS program with Dr. Simone Peters — who receive revenue share for helping develop the course content. Pricing varies by product: Nerva has a $99 upfront payment plus an $88 three-month subscription, while the Mindset subscription was priced at $11 (down from $64). The company reports that among program completers, 90% self-report reduced symptoms. Mindset plans to expand under a multi-app umbrella, delivering researcher-developed programs digitally to make them more accessible.

Participated · Series B · Apr 2022

Natural Fiber Welding (NFW) is a Peoria, Illinois–based materials-science company that engineers high-performance, plant-based alternatives to petroleum-derived plastics. Its proprietary green-chemistry platform powers two flagship products: MIRUM, an all-natural, plastic-free leather replacement, and PLIANT, the world’s first naturally cured performance rubber outsole. Together these materials form a regenerative, circular platform aimed at footwear, fashion, automotive, and industrial markets. The company positions its solutions as drop-in replacements that match or exceed conventional materials on performance, durability, and aesthetics while radically lowering carbon footprints. NFW is seeing rising demand from global brand partners and has secured strategic backing from investors such as BMW iVentures, Ralph Lauren Corporation, Allbirds, and Asahi Kasei. The latest capital will be used to accelerate commercialization, expand manufacturing capacity, and support ongoing product innovation. No revenue or user metrics were disclosed in the article.

Led · Equity · Jul 2020

Azupay is a Sydney-based fintech. On 8 July 2020 Tattarang acquired a 50% stake in Azupay for more than $4 million. Tattarang is an investment group backed by Andrew and Nicola Forrest. The article states the stake purchase price but provides no further detail on the capital structure or financing instrument beyond the equity stake. The report offers no operating metrics such as revenue, users, or profitability. No future plans or product details for Azupay are disclosed in the article.